Decentralized Energy Company (DEC), a subsidiary of Decentral Life, Inc., announced its business model to tokenize physical energy assets, starting with crude oil reserves in South America. DEC mints one token per independently validated barrel, recording detailed metadata and legal enforceability on blockchain, enabling programmable smart contracts for settlement and financing. This move taps into the rapidly growing market for tokenized real-world assets, particularly commodities and energy tax credits, which have seen explosive growth in 2026. DEC aims to provide a liquid, transparent asset for oil-producing countries, with plans to extend the model to other commodities and energy-linked instruments, while navigating regulatory and infrastructure challenges. The company also released a presentation on applying tokenization to electricity infrastructure finance, signaling broader ambitions in energy asset digitization.
Decentralized Energy Company (DEC) and its tokenization of physical energy assets are the subject, with Pluang's Energy sector market data as context. As of Oct 07, 2026 03:31 WIB, 22 of 38 priced Energy-sector US stocks on Pluang rose while 16 fell. Notable movers include BKR at USD 57.50 with a +2.68% change and 100% buy order activity, KMI at USD 32.17 with +2.42% and 85% buy orders, and TDW at USD 82.01 down -2.29%. The most notable figure is BKR's 100% buy order activity on Pluang.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
